Clinical Trial Update: Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of neoadjuvant chemotherapy plus nephroureterectomy for locally advanced upper tract urothelial carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Snippet

Sponsor: Lahey Clinic | Conditions: Transitional Cell Carcinoma | Phase 2 | Status: WITHDRAWN